Literature DB >> 21400086

Phenotype-genotype correlation in familial breast cancer.

Ana Cristina Vargas1, Jorge S Reis-Filho, Sunil R Lakhani.   

Abstract

Familial breast cancer accounts for a small but significant proportion of breast cancer cases worldwide. Identification of the candidate genes is always challenging specifically in patients with little or no family history. Therefore, a multidisciplinary team is required for the proper detection and further management of these patients. Pathologists have played a pivotal role in the cataloguing of genotypic-phenotypic correlations in families with hereditary cancer syndromes. These efforts have led to the identification of histological and phenotypic characteristics that can help predict the presence or absence of germline mutations of specific cancer predisposition genes. However, the panoply of cancer phenotypes associated with mutations of genes other than in BRCA1 is yet to be fully characterised; in fact, many cancer syndromes, germline mutations and gene sequence variants are under investigation for their possible morphological associations. Here we review the current understanding of phenotype-genotype correlation in familial breast cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21400086     DOI: 10.1007/s10911-011-9204-6

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  195 in total

1.  Is breast cancer part of the tumor spectrum of hereditary nonpolyposis colorectal cancer?

Authors:  H F Vasen; H Morreau; J W Nortier
Journal:  Am J Hum Genet       Date:  2001-06       Impact factor: 11.025

2.  Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significance.

Authors:  Georgia Chenevix-Trench; Sue Healey; Sunil Lakhani; Paul Waring; Margaret Cummings; Ross Brinkworth; Amie M Deffenbaugh; Lynn Anne Burbidge; Dmitry Pruss; Thad Judkins; Tom Scholl; Anna Bekessy; Anna Marsh; Paul Lovelock; Ming Wong; Andrea Tesoriero; Helene Renard; Melissa Southey; John L Hopper; Koulis Yannoukakos; Melissa Brown; Douglas Easton; Sean V Tavtigian; David Goldgar; Amanda B Spurdle
Journal:  Cancer Res       Date:  2006-02-15       Impact factor: 12.701

3.  Beyond BRCA1 and BRCA2 wild-type breast and/or ovarian cancer families: germline mutations in TP53 and PTEN.

Authors:  A Blanco; B Graña; L Fachal; M Santamariña; J Cameselle-Teijeiro; C Ruíz-Ponte; A Carracedo; A Vega
Journal:  Clin Genet       Date:  2009-11-23       Impact factor: 4.438

4.  Evaluation of breast involvement in relation to Cowden syndrome: a radiological and clinicopathological study of patients with PTEN germ-line mutations.

Authors:  Josep M Sabaté; Antonio Gómez; Sofía Torrubia; Carme Blancas; Gloria Sánchez; M C Alonso; E Lerma
Journal:  Eur Radiol       Date:  2005-10-06       Impact factor: 5.315

5.  Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers.

Authors:  José Palacios; Emiliano Honrado; Ana Osorio; Alicia Cazorla; David Sarrió; Alicia Barroso; Sandra Rodríguez; Juan C Cigudosa; Orland Diez; Carmen Alonso; Enrique Lerma; Joaquín Dopazo; Carmen Rivas; Javier Benítez
Journal:  Breast Cancer Res Treat       Date:  2005-03       Impact factor: 4.872

6.  Mutation of the RAD51C gene in a Fanconi anemia-like disorder.

Authors:  Fiona Vaz; Helmut Hanenberg; Beatrice Schuster; Karen Barker; Constanze Wiek; Verena Erven; Kornelia Neveling; Daniela Endt; Ian Kesterton; Flavia Autore; Franca Fraternali; Marcel Freund; Linda Hartmann; David Grimwade; Roland G Roberts; Heiner Schaal; Shehla Mohammed; Nazneen Rahman; Detlev Schindler; Christopher G Mathew
Journal:  Nat Genet       Date:  2010-04-18       Impact factor: 38.330

7.  Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer.

Authors:  Sean V Tavtigian; Peter J Oefner; Davit Babikyan; Anne Hartmann; Sue Healey; Florence Le Calvez-Kelm; Fabienne Lesueur; Graham B Byrnes; Shu-Chun Chuang; Nathalie Forey; Corinna Feuchtinger; Lydie Gioia; Janet Hall; Mia Hashibe; Barbara Herte; Sandrine McKay-Chopin; Alun Thomas; Maxime P Vallée; Catherine Voegele; Penelope M Webb; David C Whiteman; Suleeporn Sangrajrang; John L Hopper; Melissa C Southey; Irene L Andrulis; Esther M John; Georgia Chenevix-Trench
Journal:  Am J Hum Genet       Date:  2009-09-24       Impact factor: 11.025

8.  Screening-detected breast carcinoma in a patient with Cowden syndrome.

Authors:  M G Baù; R Arisio; G Cristini; E Bertone; M Campogrande
Journal:  Breast       Date:  2004-06       Impact factor: 4.380

9.  Expression of BRCA1 protein in breast cancer and its prognostic significance.

Authors:  Emad A Rakha; Somaia E El-Sheikh; Mona A Kandil; Maysa E El-Sayed; Andrew R Green; Ian O Ellis
Journal:  Hum Pathol       Date:  2008-04-08       Impact factor: 3.466

10.  CCND1 amplification and cyclin D1 expression in breast cancer and their relation with proteomic subgroups and patient outcome.

Authors:  Somaia Elsheikh; Andrew R Green; Mohammed A Aleskandarany; Matthew Grainge; Claire E Paish; Maryou B K Lambros; Jorge S Reis-Filho; Ian O Ellis
Journal:  Breast Cancer Res Treat       Date:  2007-07-26       Impact factor: 4.872

View more
  11 in total

1.  Should BRCA2 mutation carriers avoid neoadjuvant chemotherapy?

Authors:  J Raphael; C Mazouni; O Caron; M Ferchiou; S Delaloge
Journal:  Med Oncol       Date:  2014-01-22       Impact factor: 3.064

Review 2.  Genotype/Phenotype correlations in patients with hereditary breast cancer.

Authors:  Maike Wittersheim; Reinhard Büttner; Birgid Markiefka
Journal:  Breast Care (Basel)       Date:  2015-02       Impact factor: 2.860

3.  Are synchronous and metachronous bilateral breast cancers different? An immunohistochemical analysis aimed at intrinsic tumor phenotype.

Authors:  Elżbieta Senkus; Jolanta Szade; Beata Pieczyńska; Anna Zaczek; Joanna Pikiel; Katarzyna Sosińska-Mielcarek; Agnieszka Karpińska; Jacek Jassem
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

Review 4.  The complex genetic landscape of familial breast cancer.

Authors:  Lorenzo Melchor; Javier Benítez
Journal:  Hum Genet       Date:  2013-04-05       Impact factor: 4.132

5.  Peroxisome proliferator-activated receptor gamma (PPARG) polymorphisms and breast cancer susceptibility: a meta-analysis.

Authors:  Weifeng Tang; Yuanmei Chen; Yafeng Wang; Haiyong Gu; Shuchen Chen; Mingqiang Kang
Journal:  Int J Clin Exp Med       Date:  2015-08-15

Review 6.  Hereditary breast cancer: clinical, pathological and molecular characteristics.

Authors:  Martin J Larsen; Mads Thomassen; Anne-Marie Gerdes; Torben A Kruse
Journal:  Breast Cancer (Auckl)       Date:  2014-10-15

7.  Targeted RNA-seq successfully identifies normal and pathogenic splicing events in breast/ovarian cancer susceptibility and Lynch syndrome genes.

Authors:  Rita D Brandão; Klaas Mensaert; Irene López-Perolio; Demis Tserpelis; Markos Xenakis; Vanessa Lattimore; Logan C Walker; Anders Kvist; Ana Vega; Sara Gutiérrez-Enríquez; Orland Díez; Miguel de la Hoya; Amanda B Spurdle; Tim De Meyer; Marinus J Blok
Journal:  Int J Cancer       Date:  2019-02-07       Impact factor: 7.396

8.  VEGF, HIF-1α expression and MVD as an angiogenic network in familial breast cancer.

Authors:  Concetta Saponaro; Andrea Malfettone; Girolamo Ranieri; Katia Danza; Giovanni Simone; Angelo Paradiso; Anita Mangia
Journal:  PLoS One       Date:  2013-01-11       Impact factor: 3.240

9.  RNA profiling reveals familial aggregation of molecular subtypes in non-BRCA1/2 breast cancer families.

Authors:  Martin J Larsen; Mads Thomassen; Qihua Tan; Anne-Vibeke Lænkholm; Martin Bak; Kristina P Sørensen; Mette Klarskov Andersen; Torben A Kruse; Anne-Marie Gerdes
Journal:  BMC Med Genomics       Date:  2014-01-31       Impact factor: 3.063

10.  Long-term survival and BRCA status in male breast cancer: a retrospective single-center analysis.

Authors:  Piera Gargiulo; Matilde Pensabene; Monica Milano; Grazia Arpino; Mario Giuliano; Valeria Forestieri; Caterina Condello; Rossella Lauria; Sabino De Placido
Journal:  BMC Cancer       Date:  2016-07-04       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.